Löffler’s endocarditis is a condition that occurs in patients with hypereosinophilic syndrome (HES). First described in 1975, HES is a relatively new syndrome that is characterized by elevated eosinophils with end organ damage. Hypereosinophilia is defined as elevated eosinophils of 1.5 x 109/L for at least one month, or tissue involvement as evidenced by bone marrow section with 20% eosinophils, tissue infiltration, and/or deposition of eosinophil granule proteins in tissue. Prevalence of HES in the United States is estimated to be 0.36–6.3/ 100,000 people, of which Löffler’s endocarditis represents only a fraction of cases. We present a case where a patient presented with palpitations and shortness of breath, with a background of chronically elevated eosinophils. HES was previously diagnosed in this patient due to persistently elevated eosinophils with lung damage (Löffler’s syndrome). On biopsy, she was found to have endomyocardial fibrosis with a thickened endocardium secondary to eosinophils. Echocardiogram showed moderate to severe regurgitation in both mitral and tricuspid valves due to regurgitation secondary to fibrosis. She subsequently underwent a successful dual valve replacement. This is the first case, to our knowledge, where a dual valve replacement was performed successfully in a patient with Löffler’s endocarditis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.